Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University
Chicago, United States
Kwang-Soo Kim is a clinical research associate at Northwestern University's Malnati Brain Tumor Institute where he investigates novel immunotherapies for the treatment of glioblastoma. Before joining Northwestern University, he completed his PhD studies at the CHA University in South Korea where he uncovered the role of ELK3 in modulating the tumor microenvironment and tumor metastasis.
